share_log

NeuroBo Pharmaceuticals | 8-K: The Board of Directors of Neurobo Pharmaceuticals Appointed Mr. Marshall H. Woodworth as the Company’s Acting Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer

SEC announcement ·  Oct 30, 2023 08:06
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more